Therapeutic Anticoagulation for Isolated Calf Deep Vein Thrombosis
- PMID: 27437827
- DOI: 10.1001/jamasurg.2016.1770
Therapeutic Anticoagulation for Isolated Calf Deep Vein Thrombosis
Abstract
Importance: Deep vein thrombosis (DVT) isolated to the calf veins (distal to the popliteal vein) is frequently detected with duplex ultrasonography and may result in proximal thrombosis or pulmonary embolism (PE).
Objective: To evaluate whether therapeutic anticoagulation is associated with a decreased risk for proximal DVT or PE after diagnosis of an isolated calf DVT.
Design, setting, and participants: All adult patients with ultrasonographic detection of an isolated calf DVT from January 1, 2010, to December 31, 2013, at the Vascular Laboratory of the University of California, Davis, Medical Center were included. Patients already receiving therapeutic anticoagulation and those with a chronic calf DVT, a contraindication to anticoagulation, prior venous thromboembolism within 180 days, or diagnosis of a PE suspected at the time of calf DVT diagnosis were excluded. Data were analyzed from August 18, 2015, to February 14, 2016.
Exposures: Intention to administer therapeutic anticoagulation.
Main outcomes and measures: Proximal DVT or PE within 180 days of the diagnosis of the isolated calf DVT.
Results: From 14 056 lower-extremity venous duplex studies, we identified 697 patients with an isolated calf DVT and excluded 313 of these. The remaining 384 patients were available for analysis (222 men [57.8%]; 162 women [42.2%]; mean [SD] age, 60 [16] years). The calf DVT involved an axial vein (anterior tibial, posterior tibial, or peroneal) in 243 patients (63.2%) and a muscular branch (soleus or gastrocnemius) in 215 (56.0%). Physicians attempted to administer therapeutic anticoagulation in 243 patients (63.3%), leaving 141 control participants. Proximal DVT occurred in 7 controls (5.0%) and 4 anticoagulation recipients (1.6%); PE, in 6 controls (4.3%) and 4 anticoagulation recipients (1.6%). Therapeutic anticoagulation was associated with a decreased risk for proximal DVT or PE at 180 days (odds ratio [OR], 0.34; 95% CI, 0.14-0.83) but an increased risk for bleeding (OR, 4.35; 95% CI, 1.27-14.9), findings that persisted after adjustment for confounding factors (ORs, 0.33 [95% CI, 0.12-0.87] and 4.87 [95% CI, 1.37-17.3], respectively) and sensitivity analyses.
Conclusions and relevance: Rates of proximal DVT or PE are low after isolated calf DVT. Therapeutic anticoagulation is associated with a reduction of these outcomes but an increase in bleeding.
Comment in
-
Significance of Isolated Calf Vein Thrombosis-Further Evidence.JAMA Surg. 2016 Sep 21;151(9):e161799. doi: 10.1001/jamasurg.2016.1799. Epub 2016 Sep 21. JAMA Surg. 2016. PMID: 27438784 No abstract available.
-
Do isolated calf deep vein thrombosis need anticoagulant treatment?J Thorac Dis. 2016 Dec;8(12):E1691-E1693. doi: 10.21037/jtd.2016.12.93. J Thorac Dis. 2016. PMID: 28149615 Free PMC article. No abstract available.
-
The Risks and Benefits of Treating Isolated Calf Deep Vein Thrombosis: Terms To Discuss With Your Patient.JAMA Surg. 2017 Jun 1;152(6):605-606. doi: 10.1001/jamasurg.2016.5560. JAMA Surg. 2017. PMID: 28199451 No abstract available.
-
The Risks and Benefits of Treating Isolated Calf Deep Vein Thrombosis-Reply.JAMA Surg. 2017 Jun 1;152(6):606. doi: 10.1001/jamasurg.2016.5563. JAMA Surg. 2017. PMID: 28199480 No abstract available.
Similar articles
-
Clinical presentation of isolated calf deep vein thrombosis in inpatients and prevalence of associated pulmonary embolism.J Vasc Surg Venous Lymphat Disord. 2022 Sep;10(5):1037-1043. doi: 10.1016/j.jvsv.2022.02.011. Epub 2022 Feb 23. J Vasc Surg Venous Lymphat Disord. 2022. PMID: 35218959
-
Rediscussing Anticoagulation in Distal Deep Venous Thrombosis.Clin Appl Thromb Hemost. 2016 Nov;22(8):772-778. doi: 10.1177/1076029615627343. Epub 2016 Jan 19. Clin Appl Thromb Hemost. 2016. PMID: 26787712
-
The controversy of managing calf vein thrombosis.J Vasc Surg. 2012 Feb;55(2):550-61. doi: 10.1016/j.jvs.2011.05.092. Epub 2011 Oct 26. J Vasc Surg. 2012. PMID: 22032881 Review.
-
Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trial.Lancet Haematol. 2016 Dec;3(12):e556-e562. doi: 10.1016/S2352-3026(16)30131-4. Epub 2016 Nov 8. Lancet Haematol. 2016. PMID: 27836513 Clinical Trial.
-
[Epidemiology and management of isolated distal deep venous thrombosis].Rev Med Interne. 2012 Dec;33(12):678-85. doi: 10.1016/j.revmed.2012.05.012. Epub 2012 Jun 15. Rev Med Interne. 2012. PMID: 22705030 Review. French.
Cited by
-
Isolated Calf Muscle Venous Thrombosis: A Review of Anticoagulation Strategies.Med Sci Monit. 2024 Jul 10;30:e943955. doi: 10.12659/MSM.943955. Med Sci Monit. 2024. PMID: 38985697 Free PMC article. Review.
-
Recurrence in isolated distal DVT after anticoagulation: a systematic review and meta-analysis of axial and muscular venous thrombosis.Thromb J. 2024 Jul 1;22(1):57. doi: 10.1186/s12959-024-00623-6. Thromb J. 2024. PMID: 38951855 Free PMC article. Review.
-
Padua prediction score may be inappropriate for VTE risk assessment in hospitalized patients with acute respiratory conditions: A Chinese single-center cohort study.Int J Cardiol Heart Vasc. 2023 Nov 15;49:101301. doi: 10.1016/j.ijcha.2023.101301. eCollection 2023 Dec. Int J Cardiol Heart Vasc. 2023. PMID: 38035260 Free PMC article.
-
The clinical outcomes of different doses of rivaroxaban in patients with isolated distal deep vein thrombosis.J Vasc Surg Venous Lymphat Disord. 2024 Mar;12(2):101653. doi: 10.1016/j.jvsv.2023.07.008. Epub 2023 Jul 23. J Vasc Surg Venous Lymphat Disord. 2024. PMID: 37490950 Free PMC article.
-
Just the facts: POCUS assessment for deep venous thrombosis.CJEM. 2023 Apr;25(4):291-293. doi: 10.1007/s43678-022-00410-0. Epub 2022 Nov 17. CJEM. 2023. PMID: 36396896 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
